Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation

NCT00402363 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

663

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibrillation, Atrial

Interventions

DRUG: omega-3-acid ethyl esters
DRUG: Placebo

Sponsor

GlaxoSmithKline